Management of Tachypnea in Elderly Ex-Smokers

Assessment and Nebulization

For patients without diagnosed respiratory disease, nebulized bronchodilators should not be administered routinely when oxygen saturation is normal (95%) 1
Tachypnea alone (respiratory rate of 24/min) without hypoxemia or diagnosed airflow obstruction is not an indication for nebulized bronchodilator therapy 1, 3
In elderly patients without established asthma or COPD, bronchodilator therapy should be reserved for those with evidence of airflow obstruction 4

Nebulized β-agonists like salbutamol can cause tremor, which is especially problematic in elderly patients 2
Elderly patients with potential ischemic heart disease are at higher risk of cardiac side effects from β-agonists and may require ECG monitoring during first dose administration 2
Unnecessary bronchodilator therapy may mask symptoms of underlying conditions requiring different treatment 1

For most patients without risk of hypercapnic respiratory failure, the target oxygen saturation range is 94-98%, which this patient already meets without intervention 6, 3
Oxygen should be administered only if saturation falls below the target range 1, 6
Continue to monitor respiratory rate, oxygen saturation, and work of breathing 1
If the patient's condition worsens, arterial blood gas analysis should be considered to assess for hypercapnia 1
Carefully evaluate for other causes of tachypnea including cardiac issues, pulmonary embolism, or infection 6